3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
20
Breast Neoplasms
10
Carcinoma, Ovarian Epithelial
8
Sarcoma
6
Neoplasms
4
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Sarcoma, Kaposi
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
AIDS-related Kaposi sarcoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Paclitaxel
4
Cyclophosphamide
4
exemestane
3
Taxes
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Anastrozole
3
Trastuzumab
2
Leuprolide
2
Immunotherapy
2
Goserelin
2
Carboplatin
2
trastuzumab biosimilar HLX02
1
ribociclib
1
pegfilgrastim
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Vitamins
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Omeprazole
1
Ogivri
1
Neoadjuvant Therapy
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
liposomal doxorubicin
×
1 year
×
Clear all
No trials found.